Market Place
Sourcing Support
YS Biopharma Announces Name Change to LakeShore Biopharma
24 May 2024 //
PR NEWSWIRE
YS Biopharma Announces Results of Extraordinary General Meeting
21 May 2024 //
PR NEWSWIRE
YS Biopharma EGM On May 21, Appoints Interim CEO
07 May 2024 //
PR NEWSWIRE
YS Biopharma Gets 180 Day Nasdaq Extension for Minimum Bid Compliance
29 Apr 2024 //
PR NEWSWIRE
YS Biopharma Reports Unaudited First 9 Months FY2024 Financials
19 Apr 2024 //
PR NEWSWIRE
YS Biopharma Gets Phase 1 Trial Approval For HBV Vaccine
18 Apr 2024 //
PR NEWSWIRE
YS Biopharma`s rabies vaccine beats approved competitor in ph. 3
10 Apr 2024 //
FIERCE BIOTECH
YS Biopharma Positive Interim PIKA Rabies Vaccine Phase 3 Results
09 Apr 2024 //
PR NEWSWIRE
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
03 Apr 2024 //
PR NEWSWIRE
YS Biopharma Announces Board Changes and Strategic Leadership Appointments
05 Mar 2024 //
PR NEWSWIRE
Noble Capital Markets Initiates Coverage on YS Biopharma
14 Nov 2023 //
PR NEWSWIRE
YS Bio Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial
26 Sep 2023 //
PR NEWSWIRE
YishengBio Received Approvals For Phase 2 / 3 Trials of PIKA Recombinant vaccine
08 Sep 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.